Capital World Investors Pfizer Inc Transaction History

Capital World Investors

$586 Billion
Q1 2024

A detailed history of Capital World Investors transactions in Pfizer Inc stock. As of the latest transaction made, Capital World Investors holds 112,661,481 shares of PFE stock, worth $3.23 Billion. This represents 0.53% of its overall portfolio holdings.

Number of Shares

112,661,481

Previous 173,394,272 35.03%

Holding current value

$3.23 Billion

Previous $4.99 Billion 37.37%

% of portfolio

0.53%

Previous 0.91%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$25.89 - $29.73 $1.57 Billion - $1.81 Billion	-60,732,791 Reduced 35.03%	112,661,481 $3.13 Billion
Q4 2023 Feb 13, 2024	SELL	$26.13 - $33.94 $230 Million - $299 Million	-8,798,010 Reduced 4.83%	173,394,272 $4.99 Billion
Q3 2023 Nov 13, 2023	SELL	$32.09 - $37.51 $540 Million - $631 Million	-16,820,524 Reduced 8.45%	182,192,282 $6.04 Billion
Q2 2023 Aug 11, 2023	SELL	$36.12 - $41.79 $1.17 Billion - $1.36 Billion	-32,499,562 Reduced 14.04%	199,012,806 $7.3 Billion
Q1 2023 May 15, 2023	SELL	$39.39 - $51.28 $968 Million - $1.26 Billion	-24,584,436 Reduced 9.6%	231,512,368 $9.45 Billion

Q4 2022 Feb 14, 2023	BUY	$41.75 - $54.5 $303 Million - $395 Million	7,246,275 Added 2.91%	256,096,804 $13.1 Billion
Q3 2022 Nov 14, 2022	SELL	$43.76 - $53.42 $55.8 Million - $68.2 Million	-1,276,218 Reduced 0.51%	248,850,529 $10.9 Billion
Q2 2022 Aug 15, 2022	BUY	$46.53 - $55.17 $1.41 Billion - $1.67 Billion	30,250,912 Added 13.76%	250,126,747 $13.1 Billion
Q1 2022 May 16, 2022	SELL	$45.75 - $56.69 $777 Million - $963 Million	-16,982,581 Reduced 7.17%	219,875,835 $11.4 Billion
Q4 2021 Feb 14, 2022	SELL	$41.32 - $61.25 $186 Million - $276 Million	-4,502,442 Reduced 1.87%	236,858,416 $14 Billion
Q3 2021 Nov 15, 2021	BUY	$39.25 - $50.42 $46 Million - $59.1 Million	1,171,443 Added 0.49%	241,360,858 $10.4 Billion
Q2 2021 Aug 16, 2021	BUY	$35.91 - $40.68 $363 Million - $411 Million	10,103,021 Added 4.39%	240,189,415 $9.41 Billion
Q1 2021 May 14, 2021	SELL	$33.49 - $37.77 $1.22 Billion - $1.38 Billion	-36,561,224 Reduced 13.71%	230,086,394 $8.34 Billion
Q4 2020 Feb 12, 2021	BUY	$33.47 - $42.56 $250 Million - $318 Million	7,461,321 Added 2.88%	266,647,618 $9.82 Billion
Q3 2020 Nov 13, 2020	BUY	$31.75 - $37.25 $468 Million - $549 Million	14,747,788 Added 6.03%	259,186,297 $9.51 Billion
Q2 2020 Aug 14, 2020	BUY	$30.12 - $36.54 $591 Million - $717 Million	19,630,396 Added 8.73%	244,438,509 $7.99 Billion
Q1 2020 May 15, 2020	BUY	$27.03 - $38.62 $976 Million - $1.39 Billion	36,092,723 Added 19.13%	224,808,113 $7.34 Billion
Q4 2019 Feb 18, 2020	BUY	$32.92 - $37.36 $732 Million - $831 Million	22,232,056 Added 13.35%	188,715,390 $7.39 Billion
Q3 2019 Nov 14, 2019	BUY	$32.49 - $42.13 $146 Million - $189 Million	4,492,241 Added 2.77%	166,483,334 $5.98 Billion
Q2 2019 Aug 14, 2019	BUY	$36.98 - $41.52 $505 Million - $567 Million	13,656,468 Added 9.21%	161,991,093 $7.02 Billion
Q1 2019 May 15, 2019	BUY	$37.5 - $41.2 $859 Million - $944 Million	22,911,985 Added 18.27%	148,334,625 $6.3 Billion
Q4 2018 Feb 14, 2019	BUY	$38.47 - $43.86 $1.55 Billion - $1.77 Billion	40,389,680 Added 47.5%	125,422,640 $5.47 Billion
Q3 2018 Nov 14, 2018	BUY	$34.47 - $41.81 $1.63 Billion - $1.97 Billion	47,202,436 Added 124.77%	85,032,960 $3.75 Billion
Q2 2018 Aug 14, 2018	BUY	$32.98 - $35.16 $689 Million - $735 Million	20,895,524 Added 123.39%	37,830,524 $1.37 Billion
Q3 2017 Nov 14, 2017	BUY	$31.0 - $34.15 $525 Million - $578 Million	16,935,000	16,935,000 $605 Million

Others Institutions Holding PFE

# of Institutions

3,155

Shares Held

3.68B

Call Options Held

67.4M

Put Options Held

113M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $161B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital World Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital World Investors with notifications on news.

Account

Capital World Investors Pfizer Inc Transaction History